TB
Tolerance Bio
AgeTech
About
Tolerance Bio develops immunological and therapeutic solutions focused on age-related diseases and age-associated immune dysfunction. The company leverages biotech innovation to address tolerance mechanisms that decline with aging, supporting healthier longevity outcomes.
Is this your company?
Claim this listing to update your profile, add your logo, and reach buyers searching for AgeTech.
Key facts
FundingPrivate
SectorAgeTech
Are you Tolerance Bio?
Claim your profile
Upgrade to Premium for a full profile, featured badge, logo, and contact button.
Get premium listing →